Genmab A/S announced today that the European Commission (EC) has granted marketing authorization for TIVDAK® (tisotumab vedotin), an antibody-drug conjugate (ADC), as monotherapy treatment for adult ...
As one of the nation’s leading academic medical centers, VUMC is at the forefront of advancing healthcare through cutting-edge research and clinical excellence. Through the luminary program with VUMC, ...
9h
Charles Schwab Investment Management Inc. raised its stake in shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA – Free Report) by 3.2% during the fourth quarter, HoldingsChannel reports. The firm owned ...
StockNews.com initiated coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a report published on Sunday. The firm ...
We provide severe weather warnings and coastal hazard warnings for potentially hazardous or dangerous weather that is not solely related to severe thunderstorms, tropical cyclones or bushfires. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback